Transactions involving new technologies and their related intangible assets have grown steadily. Restarting the world’s economic engines after the Coronavirus-induced shutdown suggests that such transactions may increase rapidly as firms seek to gain immediate value from their non-core assets. This webinar provides a context for valuation and discusses its role in commercial transactions (investment, M&A, divestment or licensing) from Tom Ewing at AWA Strategy.
Valuation for Technology & IP Transactions in Good Times & Bad
You may also be interested in:
AI and Intellectual Property
In this webinar from December 2024, Henrik Aurell, European Patent Attorney, and Hanna Hansson, IP Lawyer, deliver a presentation
New rules for medical devices and in vitro diagnostic medical devices
In recent years, several new and amended requirements have been introduced for medical devices and in vitro diagnostic devices